{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:06:35Z","timestamp":1780758395245,"version":"3.54.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T00:00:00Z","timestamp":1718323200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1007\/s10067-024-07032-0","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T18:02:46Z","timestamp":1718388166000},"page":"2445-2452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Body mass index stratification enables cytokine-based prediction of ACPA status and Power-Doppler disease activity in rheumatoid arthritis"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6320-4818","authenticated-orcid":false,"given":"O.","family":"Gadeholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"4","key":"7032_CR1","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.berh.2014.10.016","volume":"28","author":"AG Pratt","year":"2014","unstructured":"Pratt AG, Isaacs JD (2014) Seronegative rheumatoid arthritis: pathogenetic and therapeutic aspects. Best Pract Res Clin Rheumatol 28(4):651\u2013659. https:\/\/doi.org\/10.1016\/j.berh.2014.10.016. (Epub 2014 Nov 18 PMID: 25481556)","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"8","key":"7032_CR2","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00296-016-3506-3","volume":"36","author":"E Martin-Mola","year":"2016","unstructured":"Martin-Mola E, Balsa A, Garc\u00eda-Vicuna R et al (2016) Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review. Rheumatol Int 36(8):1043\u20131063","journal-title":"Rheumatol Int"},{"issue":"1","key":"7032_CR3","first-page":"37","volume":"37","author":"K Paalanen","year":"2019","unstructured":"Paalanen K, Rannio K, Asikainen J et al (2019) Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. Clin Exp Rheumatol 37(1):37\u201343","journal-title":"Clin Exp Rheumatol"},{"key":"7032_CR4","unstructured":"Gadeholt O (2017) Rheumatoid arthritis is not a single disease. Clin Exp Rheumatol 35 Suppl 104(2):20\u201321"},{"issue":"1","key":"7032_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR et al (2016) Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 75(1):3\u201315","journal-title":"Ann Rheum Dis"},{"key":"7032_CR6","unstructured":"van Riel PL, Renskers L (2016) The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin Exp Rheumatol 34(5 Suppl 101):S40\u2013S44"},{"issue":"3","key":"7032_CR7","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/annrheumdis-2020-216999","volume":"80","author":"RBM Landew\u00e9","year":"2020","unstructured":"Landew\u00e9 RBM, van der Heijde D (2020) Use of multidimensional composite scores in rheumatology: parsimony versus subtlety. Ann Rheum Dis 80(3):280\u2013285. https:\/\/doi.org\/10.1136\/annrheumdis-2020-216999","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"7032_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/RHU.0b013e3181b126b1","volume":"15","author":"K Lindsay","year":"2009","unstructured":"Lindsay K, Ibrahim G, Sokoll K et al (2009) The composite DAS score is impractical to use in daily practice: evidence that physicians use the objective component of the DAS in decision making. J Clin Rheumatol 15(5):223\u2013225. https:\/\/doi.org\/10.1097\/RHU.0b013e3181b126b1. (PMID: 19590441)","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"7032_CR9","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1002\/art.30634","volume":"63","author":"D Aletaha","year":"2011","unstructured":"Aletaha D, Smolen JS (2011) Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints. Arthritis Rheum 63(12):3702\u20133711. https:\/\/doi.org\/10.1002\/art.30634. (PMID: 21953215)","journal-title":"Arthritis Rheum"},{"issue":"3","key":"7032_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/BOR.0b013e32835fad45","volume":"25","author":"S Ohrndorf","year":"2013","unstructured":"Ohrndorf S, Werner SG, Finzel S et al (2013) Musculoskeletal ultrasound and other imaging modalities in rheumatoid arthritis. Curr Opin Rheumatol 25(3):367\u2013374. https:\/\/doi.org\/10.1097\/BOR.0b013e32835fad45. (PMID: 23466958)","journal-title":"Curr Opin Rheumatol"},{"key":"7032_CR11","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/art.10784","volume":"48","author":"C Weidekamm","year":"2003","unstructured":"Weidekamm C, K\u00f6ller M, Weber M et al (2003) Diagnostic value of high-resolution B-mode and Doppler sonography for imaging of hand and finger joints in rheumatoid arthritis. Arthritis Rheum 48:325\u2013333","journal-title":"Arthritis Rheum"},{"key":"7032_CR12","doi-asserted-by":"publisher","first-page":"R78","DOI":"10.1186\/ar3341","volume":"13","author":"HB Hammer","year":"2011","unstructured":"Hammer HB, Kvien TK (2011) Comparisons of 7- to 78-joint ultrasonography scores: all different joint combinations show equal response to adalimumab treatment in patients with rheumatoid arthritis. Arthritis Res Ther 13:R78","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"7032_CR13","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/rheumatology\/keq190","volume":"50","author":"L Barra","year":"2011","unstructured":"Barra L, Pope J, Bessette L et al (2011) Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review. Rheumatology (Oxford) 50(2):311\u2013316. https:\/\/doi.org\/10.1093\/rheumatology\/keq190. (Epub 2010 Jul 9 PMID: 20621983)","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"7032_CR14","first-page":"1793","volume":"28","author":"AJ Schuerwegh","year":"2001","unstructured":"Schuerwegh AJ, van Offel JF, Bridts CH et al (2001) Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis. J Rheumatol 28(8):1793\u20131799 (PMID: 11508581)","journal-title":"J Rheumatol"},{"issue":"3","key":"7032_CR15","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","volume":"163","author":"P Charles","year":"1999","unstructured":"Charles P, Elliott MJ, Davis D et al (1999) Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 163(3):1521\u20131528 (PMID: 10415055)","journal-title":"J Immunol"},{"issue":"1","key":"7032_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.semarthrit.2020.11.005","volume":"51","author":"JE Pope","year":"2021","unstructured":"Pope JE, Choy EH (2021) C-reactive protein and implications in rheumatoid arthritis and associated comorbidities. Semin Arthritis Rheum 51(1):219\u2013229. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.11.005. (Epub 2020 Dec 17 PMID: 33385862)","journal-title":"Semin Arthritis Rheum"},{"key":"7032_CR17","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1002\/art.39716","volume":"68","author":"JM Davis","year":"2016","unstructured":"Davis JM (2016) Editorial: The multi-biomarker disease activity test for rheumatoid arthritis: is it a valid measure of disease activity? Arthritis & Rheumatology 68:2061\u20132066. https:\/\/doi.org\/10.1002\/art.39716","journal-title":"Arthritis & Rheumatology"},{"key":"7032_CR18","unstructured":"https:\/\/www.who.int\/health-topics\/obesity#tab=tab_1. Accessed 12 June 2024"},{"key":"7032_CR19","doi-asserted-by":"publisher","unstructured":"George MD, Giles JT, Katz PP et al (2017) Impact of obesity and adiposity on inflammatory markers in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken) 69(12):1789\u20131798. https:\/\/doi.org\/10.1002\/acr.23229. Epub 2017 Nov 6. PMID: 28393498; PMCID: PMC5634905","DOI":"10.1002\/acr.23229"},{"issue":"2","key":"7032_CR20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1152\/physrev.1999.79.2.451","volume":"79","author":"E J\u00e9quier","year":"1999","unstructured":"J\u00e9quier E, Tappy L (1999) Regulation of body weight in humans. Physiol Rev 79(2):451\u2013480. https:\/\/doi.org\/10.1152\/physrev.1999.79.2.451. (PMID: 10221987)","journal-title":"Physiol Rev"},{"issue":"5","key":"7032_CR21","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.3390\/ijms23052859.PMID:35270000;PMCID:PMC8911522","volume":"23","author":"D Ait Eldjoudi","year":"2022","unstructured":"Ait Eldjoudi D, Cordero Barreal A, Gonzalez-Rodr\u00edguez M et al (2022) Leptin in osteoarthritis and rheumatoid arthritis: player or bystander? Int J Mol Sci 23(5):2859. https:\/\/doi.org\/10.3390\/ijms23052859.PMID:35270000;PMCID:PMC8911522","journal-title":"Int J Mol Sci"},{"issue":"9","key":"7032_CR22","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584. (PMID: 20872595)","journal-title":"Arthritis Rheum"},{"key":"7032_CR23","unstructured":"R Core Team (2022) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.\u00a0https:\/\/www.R-project.org\/. Accessed 1 Nov 2023"},{"issue":"2","key":"7032_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nmeth.3252","volume":"12","author":"W Huber","year":"2015","unstructured":"Huber W, Carey VJ, Gentleman R et al (2015) Orchestrating high-throughput genomic analysis with bioconductor. Nat Methods 12(2):115\u2013121. https:\/\/doi.org\/10.1038\/nmeth.3252. (PMID: 25633503)","journal-title":"Nat Methods"},{"key":"7032_CR25","doi-asserted-by":"crossref","unstructured":"Fox J, Weisberg S (2018) An R companion to applied regression, 2nd edn. SAGE Publications, Inc","DOI":"10.32614\/CRAN.package.carData"},{"key":"7032_CR26","doi-asserted-by":"crossref","unstructured":"Friedman J, Hastie T, Tibshirani R (2010) Regularization paths for generalized linear models via coordinate descent. J Stat Softw 33(1):1\u201322.\u00a0https:\/\/www.jstatsoft.org\/v33\/i01\/.\u00a0Accessed 1 Nov 2023","DOI":"10.18637\/jss.v033.i01"},{"issue":"12","key":"7032_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77.PMID:21414208;PMCID:PMC3068975","volume":"17","author":"X Robin","year":"2011","unstructured":"Robin X, Turck N, Hainard A et al (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 17(12):77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.PMID:21414208;PMCID:PMC3068975","journal-title":"BMC Bioinformatics"},{"issue":"20","key":"7032_CR28","doi-asserted-by":"publisher","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing T, Sander O, Beerenwinkel N et al (2005) ROCR: visualizing classifier performance in R. Bioinformatics 21(20):3940\u20133941. https:\/\/doi.org\/10.1093\/bioinformatics\/bti623. (Epub 2005 Aug 11 PMID: 16096348)","journal-title":"Bioinformatics"},{"issue":"5","key":"7032_CR29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.arcmed.2021.02.002","volume":"52","author":"A Taylan","year":"2021","unstructured":"Taylan A, Akinci B, Toprak B et al (2021) Association of leptin levels and disease activity in patients with early rheumatoid arthritis. Arch Med Res 52(5):544\u2013553. https:\/\/doi.org\/10.1016\/j.arcmed.2021.02.002. (Epub 2021 Feb 23 PMID: 33632629)","journal-title":"Arch Med Res"},{"key":"7032_CR30","doi-asserted-by":"publisher","unstructured":"Hollander NK den, Boeren AMP, van der Helm-van Mil AHM et al (2024) Patients with obesity have more inflamed joints and higher CRP levels during the disease course in ACPA-positive RA but not in ACPA-negative RA. Arthritis Res Ther 26:42. https:\/\/doi.org\/10.1186\/s13075-023-03248-8","DOI":"10.1186\/s13075-023-03248-8"},{"issue":"8","key":"7032_CR31","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1093\/rheumatology\/kez535","volume":"59","author":"M Sch\u00e4fer","year":"2020","unstructured":"Sch\u00e4fer M, Mei\u00dfner Y, Kekow J et al (2020) Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis. Rheumatology (Oxford) 59(8):1916\u20131926. https:\/\/doi.org\/10.1093\/rheumatology\/kez535","journal-title":"Rheumatology (Oxford)"},{"key":"7032_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/ard-2023-225014","volume":"83","author":"JF Baker","year":"2024","unstructured":"Baker JF, O\u2019Dell JR, England BR, Giles JT et al (2024) Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis. Ann rheum dis 83:429\u2013436","journal-title":"Ann rheum dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07032-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07032-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07032-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,24]],"date-time":"2024-07-24T12:17:00Z","timestamp":1721823420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07032-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["7032"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07032-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]},"assertion":[{"value":"21 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It was not appropriate or possible to involve patients or the public in the design, conduct, reporting, or dissemination plans of our research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Gadeholt O: Honoraria: Eli Lilly; Travel grants: Galapagos, Celltrion.Arnold E, Gorman C, Mueller T, Arnold W: No conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}